IP Infusion Announces General Availability of ZebOS(R) Network Platform 7.8

SUNNYVALE, Calif., May 18 /PRNewswire/ -- IP Infusion, an ACCESS company and a leading global provider of networking protocol stacks for Next Generation Network (NGN) equipment manufacturers and converged IP services providers, today announced that it has begun shipping its ZebOS® Network Platform version 7.8 software.

The bandwidth explosion resulting from the growth of data-hungry devices on both wireless and wireline networks has put immediate pressure on service providers to upgrade their networks. ZebOS 7.8 Network Platform has been developed to enable telecommunications equipment OEMs to offer state-of-the-art equipment to service providers so they can rapidly deploy the services needed to satisfy this demand. ZebOS 7.8 provides solutions in the following areas that are of specific interest to service and network providers.

• Next Generation technology for Packet Based Transport (GMPLS support)
• Enhanced resiliency in Core networks (MPLS resiliency)
• Growing need for lower cost services in Metro (MEF Carrier Ethernet support)
• Next Generation Data Centers to manage the huge data requirements (Data Center Bridging)
• Policy routing in Access and Backhaul networks (Policy Based Routing)

ZebOS 7.8 provides support for Generalized Multiprotocol Label Switching (GMPLS) for packet and Ethernet switching (GELS). With the new 7.8 release, ZebOS provides the foundation for MPLS-TP with features such as Operations and Maintenance (OAM) for carrier-grade resilience and reliability of converged packet transport networks supporting technologies such as Ethernet pseudo wires and Label Switching Paths (LSPs). The co-existence of ZebOS MPLS and GMPLS solutions on the same node enables equipment manufacturers to unify the control and management of multi-layer networks.  

The policy based routing (PBR) in ZebOS 7.8 enables customers to have finer policies to implement forwarding and routing that go beyond traditional routing. This provides OEMs with the capability to route traffic depending on business use case.

To support carrier-grade wireless backhaul and Metro Ethernet deployments, ZebOS 7.8 added best-of-class support for Metro Ethernet service protection and service level OAM, as well as automated Ethernet service provisioning based on Metro Ethernet Forum (MEF) specifications.

ZebOS 7.8 has added support for Data Center Bridging (DCB) to enable the enhanced Quality of Service mechanisms to Ethernet required for the data center. DCB along with the other IP, Ethernet and MPLS transport technologies provides customers with a complete platform to satisfy transport needs in the data center.

"Today's networks are undergoing a major upgrade to next generation packet-based technology," said Koichi Narasaki, president and CEO, IP Infusion. "ZebOS 7.8 is targeted at filling the needs of equipment manufacturers and service providers faced with the challenges of the exploding demand for Internet bandwidth due to the new generation of data-hungry smart phones, IPTVs and Web 2.0 applications. With the features included in ZebOS 7.8, IP Infusion is changing the way network equipment manufacturers design networks, thus solidifying our role as an industry leader in providing essential, market-ready solutions to enable quick deployment of products in the expanding communications markets."

ZebOS Network Platform utilizes a scalable, resilient, modular architecture for routing and switching software. ZebOS provides customers in the service provider, enterprise router/switch and home gateway markets with robust, standards-based solutions. When combined with IP Infusion's Network Solutions Services, including consultation on network software architectures, design, technologies, protocols and product development, ZebOS delivers a complete,  fully customized solution to market.

In addition to a comprehensive suite of robust, standards-based software products, IP Infusion also provides professional services to assist customers in their product development and deployment support. With a strong product portfolio and professional services, IP Infusion can ensure the most efficient time-to-market advantage for customers.

About ACCESS

ACCESS CO., LTD. is a global company providing leading technology, software products and platforms for Web browsing, mobile phones, wireless handhelds, and other networked devices. ACCESS' product portfolio, including its NetFront™ Browser, Garnet™ OS and ACCESS Linux Platform™, provides customers with solutions that enable faster time to market, flexibility and customizability. The company, headquartered in Tokyo, Japan, operates 24 subsidiaries and affiliates within Asia, Europe and the United States. ACCESS is listed on the Tokyo Stock Exchange Mother's Index under the number 4813. For more information about ACCESS, please visit http://www.access-company.com/

About IP Infusion

IP Infusion delivers advanced software solutions that power communications equipment for packet-based Next Generation Networks (NGN). With a unique modular architecture and the industry's broadest suite of communication protocols, IP Infusion enhances product differentiation and market agility for many of the world's leading network equipment vendors. Incorporated in Delaware in October 1999, IP Infusion is headquartered in Sunnyvale, California, and is a wholly owned and independently-operated subsidiary of ACCESS Systems Americas, Inc., a wholly owned U.S. subsidiary of ACCESS CO., LTD., of Tokyo, Japan. For more information about IP Infusion, please visit www.ipinfusion.com.

ACCESS, the ACCESS logo, NetFront, ACCESS Linux Platform, Garnet are registered trademarks or trademarks of ACCESS CO., LTD. in the United States, Japan and/or other countries. IP Infusion, the IP Infusion logo and ZebOS are either registered trademarks or trademarks of IP Infusion Inc. in the United States and/or other countries. The registered trademark LINUX® is used pursuant to a sublicense from Linux Mark Institute, the exclusive licensee of Linus Torvalds, owner of the mark on a world-wide basis.

All other trademarks, logos and trade names mentioned in the document are the property of their respective owners.

SOURCE IP Infusion